AlphaFold predicted structure
MCEE · Q96PE7

Mean pLDDT
86.9/ 100
Confident
176 residues
Confidence breakdown
- Very high(≥ 90)74%
- Confident(70–90)3%
- Low(50–70)15%
- Very low(< 50)7%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
methylmalonyl-CoA epimerase
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalKetotic hypoglycaemia
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomalChildhood onset dystonia, chorea or related movement disorder
Fetal anomalies
BIALLELIC, autosomal or pseudoautosomalHyperammonaemia
Intellectual disability
BIALLELIC, autosomal or pseudoautosomalmethylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency
hereditary disease
methylmalonic acidemia
Hallux valgus
rheumatoid arthritis
dyshidrosis
bone Paget disease
complication
gastrointestinal disease
metabolic syndrome
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Methylmalonyl-CoA epimerase, mitochondrial
Methylmalonyl-CoA epimerase involved in propionyl-CoA metabolism
MCEE · Q96PE7

Mean pLDDT
86.9/ 100
Confident
176 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0